FAM-TRASTUZUMAB DERUXTECAN-NXKI

FAM-TRASTUZUMAB DERUXTECAN-NXKI was reported 10910 times

FAM-TRASTUZUMAB DERUXTECAN-NXKI is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CEREBELLAR CYST 2 0.4000
1 CHEMICAL PHLEBITIS 2 0.1429
2 NAIL BED INFLAMMATION 25 0.0784
3 PORTO-SINUSOIDAL VASCULAR DISORDER 4 0.0645
4 DRUG-DEVICE INCOMPATIBILITY 2 0.0606
5 CANCER WITH A HIGH TUMOUR MUTATIONAL BURDEN 2 0.0513
6 PSEUDOCIRRHOSIS 17 0.0512
7 HEART FAILURE WITH MIDRANGE EJECTION FRACTION 3 0.0508
8 KL-6 INCREASED 11 0.0487
9 NASAL MUCOSAL DISORDER 25 0.0429
10 RADIATION NECROSIS 24 0.0419
11 LIMBAL STEM CELL DEFICIENCY 3 0.0366
12 SKELETAL DYSPLASIA 5 0.0352
13 INTERSTITIAL LUNG ABNORMALITY 4 0.0351
14 TUMOUR MARKER DECREASED 5 0.0279
15 BRAIN RADIATION NECROSIS 2 0.0270
16 HEART FAILURE WITH REDUCED EJECTION FRACTION 14 0.0262
17 PIK3CA-ACTIVATED MUTATION 8 0.0241
18 CORONAVIRUS PNEUMONIA 4 0.0240
19 MYOCARDIAL OEDEMA 9 0.0228
20 STREPTOCOCCAL SEPSIS 27 0.0228
21 INTERSTITIAL LUNG DISEASE 1100 0.0227
22 METASTASES TO MENINGES 51 0.0224
23 METASTASES TO CENTRAL NERVOUS SYSTEM 279 0.0216
24 LYMPHANGIOSIS CARCINOMATOSA 22 0.0211
25 MALIGNANT NEOPLASM OLIGOPROGRESSION 4 0.0201
26 LEFT VENTRICULAR DILATATION 9 0.0176
27 METASTASES TO SKIN 18 0.0174
28 METASTASES TO CHEST WALL 6 0.0173
29 HEMIANOPIA 17 0.0171
30 METASTASES TO NERVOUS SYSTEM 3 0.0163
31 PNEUMONITIS 441 0.0162
32 EXOSTOSIS OF JAW 8 0.0161
33 METASTASES TO PLEURA 16 0.0153
34 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 19 0.0152
35 LUNG OPACITY 40 0.0152
36 PSEUDOMONAL SEPSIS 26 0.0148
37 PNEUMONITIS CHEMICAL 5 0.0143
38 METASTASES TO EYE 3 0.0137
39 CELL DEATH 27 0.0136
40 DIAPHRAGMATIC SPASM 2 0.0135
41 CARBOHYDRATE ANTIGEN 27.29 INCREASED 2 0.0133
42 BREAST INFLAMMATION 4 0.0130
43 DILATED CARDIOMYOPATHY 13 0.0129
44 TYPHOID FEVER 4 0.0126
45 PULMONARY TOXICITY 89 0.0126
46 TUMOUR MARKER ABNORMAL 4 0.0121
47 GAS GANGRENE 4 0.0117
48 HER2 POSITIVE BREAST CANCER 4 0.0107
49 DISEASE PROGRESSION 1257 0.0106
50 PNEUMOCYSTIS JIROVECII INFECTION 12 0.0100
51 OCULAR TOXICITY 11 0.0100
52 EXCESSIVE EYE BLINKING 14 0.0095
53 VASCULAR DEVICE INFECTION 42 0.0092
54 VENTRICULAR DYSFUNCTION 24 0.0092
55 BREAST HAEMORRHAGE 3 0.0091
56 METASTASES TO LYMPH NODES 61 0.0090
57 PNEUMOCYSTIS JIROVECII PNEUMONIA 90 0.0090
58 THROMBOPHLEBITIS MIGRANS 3 0.0088
59 LYMPHANGITIS 7 0.0087
60 CANCER IN REMISSION 2 0.0083
61 SCAN ABNORMAL 3 0.0081
62 METASTASES TO LIVER 143 0.0081
63 CARDIAC DYSFUNCTION 30 0.0081
64 NON-CIRRHOTIC PORTAL HYPERTENSION 3 0.0080
65 INTRACRANIAL TUMOUR HAEMORRHAGE 3 0.0078
66 EJECTION FRACTION DECREASED 120 0.0077
67 METASTASES TO ADRENALS 7 0.0076
68 METASTASES TO LUNG 86 0.0074
69 ONCOLOGIC COMPLICATION 7 0.0072
70 MYELOSUPPRESSION 258 0.0072
71 GASTRODUODENAL ULCER 3 0.0071
72 ABDOMINAL CAVITY DRAINAGE 3 0.0071
73 ABDOMINAL LYMPHADENOPATHY 6 0.0069
74 MEDIASTINITIS 4 0.0069
75 METASTASES TO PANCREAS 3 0.0068
76 PUNCTATE KERATITIS 6 0.0065
77 MALIGNANT ASCITES 5 0.0065
78 BLOOD BETA-D-GLUCAN INCREASED 2 0.0065
79 GASTROINTESTINAL TOXICITY 31 0.0064
80 CRITICAL ILLNESS 5 0.0064
81 THERAPY CHANGE 63 0.0064
82 GASTRIC VARICES 3 0.0064
83 HEPATIC INFECTION 8 0.0063
84 ASCITES 184 0.0063
85 NODULAR REGENERATIVE HYPERPLASIA 4 0.0062
86 PARONYCHIA 27 0.0061
87 RADIATION PNEUMONITIS 13 0.0061
88 METASTASES TO BONE MARROW 3 0.0060
89 TRIPLE NEGATIVE BREAST CANCER 4 0.0059
90 DIAPHRAGMALGIA 2 0.0058
91 ACUTE INTERSTITIAL PNEUMONITIS 3 0.0057
92 METASTASES TO BONE 93 0.0057
93 VARICOSE VEIN 29 0.0056
94 TUMOUR MARKER INCREASED 26 0.0054
95 MALIGNANT PLEURAL EFFUSION 9 0.0053
96 FOOD AVERSION 9 0.0053
97 BONE MARROW INFILTRATION 2 0.0052
98 BREAST CANCER METASTATIC 54 0.0050
99 SOFT TISSUE INFECTION 9 0.0049
100 NEUTROPHIL COUNT DECREASED 197 0.0048
101 CANCER PAIN 12 0.0047
102 PNEUMONIA BACTERIAL 43 0.0047
103 ABDOMINAL RIGIDITY 12 0.0044
104 COMPUTERISED TOMOGRAM ABNORMAL 10 0.0044
105 ANGIOSARCOMA 2 0.0043
106 HAEMATOTOXICITY 41 0.0043
107 FLUID IMBALANCE 3 0.0043
108 PORTAL HYPERTENSION 13 0.0042
109 TUMOUR HAEMORRHAGE 12 0.0042
110 CELL MARKER INCREASED 2 0.0042
111 METASTASES TO SPINE 14 0.0042
112 CARCINOEMBRYONIC ANTIGEN INCREASED 8 0.0041
113 EJECTION FRACTION ABNORMAL 5 0.0041
114 HEPATIC CYTOLYSIS 52 0.0041
115 TREATMENT DELAYED 7 0.0040
116 METASTASES TO PERITONEUM 10 0.0040
117 OBSTRUCTION GASTRIC 5 0.0039
118 BILIARY OBSTRUCTION 5 0.0039
119 CARBOHYDRATE ANTIGEN 19-9 INCREASED 2 0.0038
120 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
121 HERPES ZOSTER DISSEMINATED 3 0.0037
122 BURSITIS INFECTIVE 2 0.0037
123 LYMPHOEDEMA 25 0.0036
124 STARVATION 3 0.0036
125 EARLY SATIETY 7 0.0036
126 BRAIN SCAN ABNORMAL 2 0.0036
127 BILIARY COLIC 10 0.0034
128 INTRA-ABDOMINAL FLUID COLLECTION 6 0.0033
129 PNEUMOMEDIASTINUM 6 0.0033
130 CARDIAC DEATH 4 0.0033
131 KERATITIS 10 0.0033
132 ASPARTATE AMINOTRANSFERASE ABNORMAL 5 0.0033
133 CARDIOTOXICITY 28 0.0031
134 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
135 INTENTIONAL PRODUCT USE ISSUE 273 0.0031
136 CHORIORETINITIS 2 0.0031
137 BRAIN OEDEMA 39 0.0031
138 INTRACRANIAL PRESSURE INCREASED 17 0.0030
139 TUMOUR PAIN 4 0.0030
140 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
141 DEVICE RELATED SEPSIS 6 0.0030
142 HAEMATOLOGICAL INFECTION 7 0.0029
143 LUNG CONSOLIDATION 8 0.0029
144 ECHOCARDIOGRAM ABNORMAL 4 0.0029
145 TUMOUR NECROSIS 3 0.0028
146 RADIATION INJURY 3 0.0028
147 RESPIRATORY SYMPTOM 8 0.0028
148 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
149 MENTAL FATIGUE 4 0.0027
150 PLEURAL EFFUSION 159 0.0026
151 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
152 CYTOMEGALOVIRUS ENTEROCOLITIS 2 0.0026
153 WEIGHT ABNORMAL 6 0.0025
154 TASTE DISORDER 49 0.0024
155 IMMUNODEFICIENCY 36 0.0024
156 CAMPYLOBACTER INFECTION 2 0.0024
157 ALANINE AMINOTRANSFERASE ABNORMAL 5 0.0024
158 BLOOD BILIRUBIN INCREASED 64 0.0024
159 BLOOD BILIRUBIN ABNORMAL 3 0.0023
160 AXONAL NEUROPATHY 2 0.0023
161 MASTECTOMY 4 0.0023
162 CYTOPENIA 28 0.0023
163 SKIN FISSURES 44 0.0022
164 CYSTITIS HAEMORRHAGIC 9 0.0022
165 BLOOD ALKALINE PHOSPHATASE ABNORMAL 2 0.0022
166 ORGANISING PNEUMONIA 11 0.0022
167 BONE LESION 8 0.0022
168 BREAST CANCER RECURRENT 7 0.0022
169 MALIGNANT NEOPLASM PROGRESSION 226 0.0022
170 PANCYTOPENIA 123 0.0022
171 IMMUNE THROMBOCYTOPENIA 10 0.0022
172 NEUROLOGICAL DECOMPENSATION 5 0.0022
173 FEBRILE NEUTROPENIA 143 0.0022
174 LUNG INFILTRATION 19 0.0021
175 PERIODONTAL DISEASE 3 0.0021
176 PULMONARY FIBROSIS 41 0.0021
177 NO ADVERSE EVENT 381 0.0021
178 QUALITY OF LIFE DECREASED 28 0.0021
179 HEPATIC LESION 9 0.0021
180 ENTEROCOLITIS 12 0.0021
181 CANDIDA INFECTION 35 0.0021
182 MONOPLEGIA 9 0.0021
183 TRAUMATIC LUNG INJURY 4 0.0021
184 UNDERDOSE 148 0.0020
185 PNEUMOTHORAX 32 0.0020
186 PLATELET COUNT DECREASED 214 0.0020
187 NEUTROPENIA 273 0.0020
188 PAROSMIA 15 0.0020
189 METASTASIS 14 0.0020
190 BREAST ABSCESS 2 0.0020
191 CORONAVIRUS TEST POSITIVE 2 0.0019
192 APHTHOUS ULCER 15 0.0019
193 HEPATOTOXICITY 43 0.0019
194 PERFORMANCE STATUS DECREASED 9 0.0019
195 AXILLARY MASS 2 0.0019
196 HOSPICE CARE 19 0.0019
197 FEEDING DISORDER 39 0.0019
198 URINARY BLADDER HAEMORRHAGE 4 0.0019
199 LUNG DISORDER 92 0.0019
200 CHOLESTASIS 36 0.0019
201 HEPATIC PAIN 8 0.0019
202 ALOPECIA 366 0.0019
203 CORONAVIRUS INFECTION 12 0.0018
204 HYPOALBUMINAEMIA 14 0.0018
205 GASTRIC DILATATION 3 0.0018
206 CEREBRAL HAEMATOMA 6 0.0018
207 ANAL HAEMORRHAGE 5 0.0018
208 CHOLANGITIS 11 0.0018
209 SUSPECTED OFF LABEL USE 8 0.0018
210 DECREASED APPETITE 410 0.0018
211 IRON DEFICIENCY ANAEMIA 16 0.0017
212 HEPATIC FAILURE 52 0.0017
213 BRAIN FOG 27 0.0017
214 ELECTROLYTE IMBALANCE 20 0.0017
215 SPINAL CORD INJURY 3 0.0017
216 PULMONARY PAIN 5 0.0017
217 HEPATIC CIRRHOSIS 32 0.0017
218 JAUNDICE CHOLESTATIC 6 0.0017
219 GASTROINTESTINAL OEDEMA 3 0.0017
220 JUGULAR VEIN THROMBOSIS 3 0.0017
221 BILE DUCT CANCER 2 0.0017
222 MUCOSAL INFLAMMATION 44 0.0017
223 VOCAL CORD PARALYSIS 3 0.0017
224 BILE DUCT STENOSIS 2 0.0017
225 ARTERIOSCLEROSIS CORONARY ARTERY 11 0.0017
226 MONOPARESIS 3 0.0017
227 VARICES OESOPHAGEAL 5 0.0017
228 LUNG NEOPLASM 7 0.0016
229 FOOD INTOLERANCE 6 0.0016
230 NAUSEA 1288 0.0016
231 ULCER HAEMORRHAGE 11 0.0016
232 OPPORTUNISTIC INFECTION 3 0.0016
233 GRANULOCYTE COUNT DECREASED 3 0.0016
234 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
235 COLITIS 61 0.0016
236 FLUID INTAKE REDUCED 8 0.0016
237 ONYCHOCLASIS 11 0.0016
238 BEDRIDDEN 21 0.0016
239 PROTEIN TOTAL DECREASED 6 0.0016
240 FEMORAL NECK FRACTURE 8 0.0016
241 DEATH 1336 0.0015
242 LIVER ABSCESS 5 0.0015
243 APLASIA 3 0.0015
244 BICYTOPENIA 3 0.0015
245 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0015
246 ENCEPHALITIS AUTOIMMUNE 2 0.0015
247 NEAR DEATH EXPERIENCE 5 0.0015
248 BLOOD POTASSIUM ABNORMAL 4 0.0015
249 GASTRIC PERFORATION 4 0.0015
250 EXTRAVASATION 6 0.0015
251 THROMBOCYTOPENIA 163 0.0015
252 VENOUS THROMBOSIS LIMB 3 0.0015
253 HYPOKALAEMIA 67 0.0015
254 NEUTROPENIC COLITIS 3 0.0014
255 INFUSION SITE EXTRAVASATION 9 0.0014
256 HAIR GROWTH ABNORMAL 10 0.0014
257 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32 0.0014
258 DISCHARGE 2 0.0014
259 DIABETIC METABOLIC DECOMPENSATION 2 0.0014
260 NECROSIS 8 0.0014
261 PRODUCT ADMINISTRATION ERROR 29 0.0014
262 WHITE BLOOD CELL COUNT DECREASED 155 0.0014
263 VENOOCCLUSIVE LIVER DISEASE 7 0.0014
264 GENERAL PHYSICAL HEALTH DETERIORATION 164 0.0014
265 BLOOD ELECTROLYTES DECREASED 2 0.0014
266 METASTATIC NEOPLASM 6 0.0014
267 BLOOD MAGNESIUM DECREASED 12 0.0014
268 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
269 PATHOLOGICAL FRACTURE 7 0.0014
270 CORNEAL DISORDER 3 0.0014
271 CACHEXIA 7 0.0014
272 THORACIC VERTEBRAL FRACTURE 4 0.0014
273 CEREBRAL DISORDER 10 0.0014
274 NEOPLASM PROGRESSION 47 0.0014
275 APRAXIA 2 0.0013
276 PARESIS 3 0.0013
277 SEPTIC SHOCK 58 0.0013
278 SECOND PRIMARY MALIGNANCY 11 0.0013
279 CATHETER SITE INFECTION 5 0.0013
280 HYPERTRANSAMINASAEMIA 9 0.0013
281 INGROWING NAIL 3 0.0013
282 VOMITING 593 0.0013
283 BLOOD ALBUMIN DECREASED 10 0.0013
284 HEPATIC FUNCTION ABNORMAL 47 0.0013
285 VARICELLA 3 0.0013
286 ANAEMIA 239 0.0013
287 TUMOUR LYSIS SYNDROME 11 0.0012
288 ACUTE RESPIRATORY FAILURE 24 0.0012
289 DERMATITIS BULLOUS 9 0.0012
290 JAUNDICE 33 0.0012
291 NEUROPATHY PERIPHERAL 116 0.0012
292 LISTLESS 4 0.0012
293 GENERALISED OEDEMA 15 0.0012
294 LIVER FUNCTION TEST INCREASED 26 0.0012
295 BRAIN NEOPLASM 11 0.0012
296 CEREBELLAR INFARCTION 2 0.0012
297 GENERAL PHYSICAL CONDITION ABNORMAL 8 0.0012
298 HEPATIC ENCEPHALOPATHY 11 0.0012
299 CONSTIPATION 257 0.0012
300 ENTERITIS INFECTIOUS 2 0.0012
301 INCORRECT DRUG ADMINISTRATION RATE 5 0.0012
302 CARBOHYDRATE ANTIGEN 125 INCREASED 4 0.0012
303 LACTOSE INTOLERANCE 3 0.0012
304 PHYSICAL DECONDITIONING 3 0.0012
305 HEPATIC FIBROSIS 4 0.0012
306 PULMONARY OEDEMA 52 0.0012
307 BLOOD CHLORIDE INCREASED 2 0.0012
308 WEIGHT FLUCTUATION 12 0.0011
309 MOUTH ULCERATION 24 0.0011
310 DISSEMINATED INTRAVASCULAR COAGULATION 16 0.0011
311 C-REACTIVE PROTEIN INCREASED 41 0.0011
312 BREAST SWELLING 3 0.0011
313 FATIGUE 858 0.0011
314 DISEASE COMPLICATION 5 0.0011
315 ASTHENIA 407 0.0011
316 LOCALISED OEDEMA 5 0.0011
317 DYSENTERY 2 0.0011
318 PROCTITIS 3 0.0011
319 DRUG TOLERANCE DECREASED 3 0.0011
320 PRODUCT PREPARATION ISSUE 7 0.0011
321 BLOOD CALCIUM DECREASED 12 0.0011
322 SEPSIS 118 0.0011
323 BREAST CANCER STAGE IV 3 0.0011
324 APPETITE DISORDER 7 0.0011
325 PANCREATIC CARCINOMA METASTATIC 3 0.0011
326 PNEUMATOSIS INTESTINALIS 3 0.0011
327 SKIN HYPERPIGMENTATION 9 0.0010
328 MYOCARDITIS 12 0.0010
329 PYELONEPHRITIS 9 0.0010
330 RESTLESSNESS 38 0.0010
331 VOMITING PROJECTILE 3 0.0010
332 DYSPNOEA AT REST 3 0.0010
333 RALES 6 0.0010
334 HYPONATRAEMIA 58 0.0010
335 RESPIRATORY FAILURE 75 0.0010
336 ASPARTATE AMINOTRANSFERASE INCREASED 54 0.0010
337 LIVER DISORDER 45 0.0010
338 RED BLOOD CELL COUNT DECREASED 29 0.0010
339 PNEUMONIA FUNGAL 4 0.0010
340 HYPERVOLAEMIA 5 0.0010
341 BACTERAEMIA 12 0.0010
342 OSTEONECROSIS OF JAW 25 0.0010
343 CARDIAC FAILURE 81 0.0010
344 PULMONARY HYPERTENSION 21 0.0010
345 ATYPICAL PNEUMONIA 3 0.0010
346 PRESCRIBED UNDERDOSE 20 0.0010
347 HYPERAMMONAEMIA 5 0.0010
348 PULMONARY EMBOLISM 95 0.0010
349 INTRACRANIAL ANEURYSM 4 0.0010
350 EAR HAEMORRHAGE 2 0.0010
351 WEIGHT DECREASED 275 0.0010
352 DYSCHEZIA 3 0.0010
353 EPILEPSY 30 0.0010
354 NEUTROPENIC SEPSIS 7 0.0010
355 DIARRHOEA 632 0.0010
356 DIASTOLIC DYSFUNCTION 3 0.0010
357 DIVERTICULAR PERFORATION 2 0.0010
358 OFF LABEL USE 846 0.0010
359 ILEUS 12 0.0010
360 FAILURE TO THRIVE 5 0.0010
361 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
362 LYMPHOCYTE COUNT DECREASED 17 0.0010
363 NEOPLASM 11 0.0010
364 BLOOD SODIUM DECREASED 18 0.0010
365 ATRIAL TACHYCARDIA 2 0.0010
366 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
367 FEBRILE BONE MARROW APLASIA 4 0.0009
368 PULMONARY MASS 14 0.0009
369 ENTERITIS 6 0.0009
370 LIVER INJURY 23 0.0009
371 COVID-19 PNEUMONIA 11 0.0009
372 VULVOVAGINAL DRYNESS 3 0.0009
373 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8 0.0009
374 POLYNEUROPATHY 11 0.0009
375 GASTROINTESTINAL DISORDER 82 0.0009
376 ALANINE AMINOTRANSFERASE INCREASED 56 0.0009
377 STOMATITIS 55 0.0009
378 BLOOD CREATINE INCREASED 4 0.0009
379 CHOLESTATIC LIVER INJURY 2 0.0009
380 BLOOD POTASSIUM DECREASED 27 0.0009
381 ILEUS PARALYTIC 4 0.0009
382 TOXIC SKIN ERUPTION 9 0.0009
383 HAEMOLYTIC ANAEMIA 8 0.0009
384 EATING DISORDER 19 0.0009
385 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
386 HEPATIC CYST 3 0.0009
387 BLOOD LOSS ANAEMIA 2 0.0009
388 PNEUMONIA ASPIRATION 22 0.0009
389 HYPERSOMNIA 25 0.0009
390 ADVERSE DRUG REACTION 78 0.0009
391 OVARIAN CANCER 8 0.0009
392 DRUG-INDUCED LIVER INJURY 27 0.0009
393 HYPOPHAGIA 22 0.0009
394 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20 0.0009
395 BILIRUBIN CONJUGATED INCREASED 2 0.0009
396 DISCOURAGEMENT 2 0.0009
397 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
398 SPLENOMEGALY 10 0.0009
399 NECROTISING FASCIITIS 3 0.0009
400 HYPERCHLORHYDRIA 5 0.0008
401 HAEMOGLOBIN DECREASED 87 0.0008
402 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0008
403 MACULOPATHY 3 0.0008
404 HYPOCALCAEMIA 16 0.0008
405 DEVICE RELATED INFECTION 13 0.0008
406 HEMIPLEGIA 7 0.0008
407 DEHYDRATION 112 0.0008
408 ADVERSE REACTION 11 0.0008
409 BLOOD PHOSPHORUS DECREASED 3 0.0008
410 TOXICITY TO VARIOUS AGENTS 138 0.0008
411 PNEUMONIA 264 0.0008
412 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
413 HEPATOMEGALY 8 0.0008
414 HYPERCALCAEMIA 10 0.0008
415 LEUKOENCEPHALOPATHY 3 0.0008
416 HYDRONEPHROSIS 6 0.0008
417 GASTRITIS 21 0.0008
418 FULL BLOOD COUNT DECREASED 16 0.0008
419 ALTERED STATE OF CONSCIOUSNESS 17 0.0008
420 GASTRIC INFECTION 3 0.0008
421 OXYGEN SATURATION DECREASED 44 0.0008
422 OESOPHAGEAL ULCER 3 0.0008
423 GAIT INABILITY 26 0.0008
424 TRISMUS 4 0.0008
425 HYPERBILIRUBINAEMIA 8 0.0008
426 CARDIOPULMONARY FAILURE 3 0.0008
427 THERAPY PARTIAL RESPONDER 12 0.0008
428 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
429 FOOD CRAVING 4 0.0008
430 ORAL CANDIDIASIS 10 0.0008
431 GASTROENTERITIS 11 0.0008
432 SKIN MASS 5 0.0007
433 COMPRESSION FRACTURE 4 0.0007
434 ORGAN FAILURE 3 0.0007
435 CARDIOMYOPATHY 11 0.0007
436 COLON CANCER 11 0.0007
437 RECURRENT CANCER 3 0.0007
438 PERICARDIAL EFFUSION 17 0.0007
439 ASPHYXIA 6 0.0007
440 ARTHRITIS BACTERIAL 3 0.0007
441 PRODUCT PREPARATION ERROR 15 0.0007
442 INTESTINAL ISCHAEMIA 4 0.0007
443 ATELECTASIS 7 0.0007
444 TRANSAMINASES INCREASED 16 0.0007
445 MALNUTRITION 8 0.0007
446 ONYCHOMADESIS 3 0.0007
447 ENDOTRACHEAL INTUBATION 2 0.0007
448 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
449 BUNDLE BRANCH BLOCK LEFT 3 0.0007
450 TONGUE DISCOMFORT 3 0.0007
451 PAIN IN JAW 20 0.0007
452 CARDIAC FAILURE CHRONIC 3 0.0007
453 NEUTROPHILIA 4 0.0007
454 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
455 THERAPEUTIC RESPONSE UNEXPECTED 31 0.0007
456 BONE CANCER 3 0.0007
457 HYPOKINESIA 10 0.0007
458 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
459 HYPOVOLAEMIA 4 0.0007
460 HYPOXIA 24 0.0007
461 IMMUNOSUPPRESSION 6 0.0007
462 POOR VENOUS ACCESS 7 0.0007
463 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
464 HEPATIC ENZYME INCREASED 46 0.0007
465 PRODUCT PRESCRIBING ERROR 16 0.0007
466 CREPITATIONS 2 0.0007
467 CEREBRAL HAEMORRHAGE 24 0.0007
468 HEPATITIS 17 0.0007
469 EMBOLISM VENOUS 2 0.0007
470 DERMATITIS ACNEIFORM 4 0.0007
471 CENTRAL NERVOUS SYSTEM LESION 9 0.0007
472 DRUG INTOLERANCE 63 0.0007
473 DUODENITIS 2 0.0007
474 DYSPEPSIA 64 0.0006
475 INFUSION RELATED REACTION 43 0.0006
476 PIGMENTATION DISORDER 4 0.0006
477 HYPOMAGNESAEMIA 9 0.0006
478 AGRANULOCYTOSIS 12 0.0006
479 COUGH 181 0.0006
480 BLOOD ALKALINE PHOSPHATASE INCREASED 16 0.0006
481 LABORATORY TEST ABNORMAL 19 0.0006
482 THERAPY CESSATION 33 0.0006
483 PULMONARY THROMBOSIS 7 0.0006
484 AGEUSIA 16 0.0006
485 BLOOD CREATININE DECREASED 2 0.0006
486 LOWER RESPIRATORY TRACT INFECTION 29 0.0006
487 LYMPHOPENIA 9 0.0006
488 EOSINOPHILIC PNEUMONIA 2 0.0006
489 HYPOVOLAEMIC SHOCK 3 0.0006
490 IMPAIRED QUALITY OF LIFE 9 0.0006
491 SEIZURE 72 0.0006
492 PROCTALGIA 4 0.0006
493 CATARACT 37 0.0006
494 ENTEROCOCCAL INFECTION 3 0.0006
495 RASH VESICULAR 3 0.0006
496 FRUSTRATION TOLERANCE DECREASED 5 0.0006
497 ADVERSE EVENT 57 0.0006
498 DYSPNOEA 348 0.0006
499 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
500 SHOCK HAEMORRHAGIC 5 0.0006
501 INCORRECT DOSAGE ADMINISTERED 3 0.0006
502 MALAISE 269 0.0006
503 ILLNESS 63 0.0006
504 HICCUPS 5 0.0006
505 OSTEOMYELITIS 11 0.0006
506 SARS-COV-2 TEST POSITIVE 8 0.0006
507 COVID-19 106 0.0006
508 ABDOMINAL TENDERNESS 3 0.0006
509 RESPIRATORY DISORDER 18 0.0006
510 CARDIAC FAILURE ACUTE 4 0.0006
511 LEUKOPENIA 30 0.0006
512 FLATULENCE 34 0.0006
513 VEIN DISORDER 3 0.0006
514 ERYSIPELAS 3 0.0006
515 BREAST MASS 4 0.0006
516 COLITIS ISCHAEMIC 4 0.0006
517 HAEMATEMESIS 15 0.0006
518 CLOSTRIDIAL INFECTION 2 0.0006
519 HEPATIC STEATOSIS 11 0.0006
520 PYREXIA 204 0.0006
521 PETIT MAL EPILEPSY 3 0.0006
522 FACIAL PARALYSIS 5 0.0006
523 ENDOCARDITIS 3 0.0006
524 PERIPHERAL VASCULAR DISORDER 3 0.0006
525 BLOOD CREATININE ABNORMAL 2 0.0006
526 ADRENAL INSUFFICIENCY 7 0.0006
527 LARGE INTESTINE PERFORATION 4 0.0006
528 URINE OUTPUT DECREASED 5 0.0006
529 NAIL DISORDER 5 0.0006
530 BLOOD TEST ABNORMAL 8 0.0006
531 SMALL INTESTINAL OBSTRUCTION 7 0.0006
532 UNEVALUABLE EVENT 43 0.0006
533 BRONCHIOLITIS 2 0.0006
534 FULL BLOOD COUNT ABNORMAL 6 0.0006
535 DUODENAL ULCER 4 0.0006
536 CONJUNCTIVAL HYPERAEMIA 2 0.0006
537 ISCHAEMIC STROKE 10 0.0006
538 PARALYSIS 8 0.0006
539 GASTROINTESTINAL INFECTION 5 0.0006
540 ECZEMA 29 0.0006
541 HYDROCEPHALUS 3 0.0006
542 FEMUR FRACTURE 17 0.0005
543 ASPIRATION 6 0.0005
544 BREAST CANCER 51 0.0005
545 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
546 ABDOMINAL DISTENSION 57 0.0005
547 AMYLASE INCREASED 2 0.0005
548 UROSEPSIS 5 0.0005
549 DRY EYE 27 0.0005
550 MENTAL IMPAIRMENT 13 0.0005
551 PRODUCT LEAKAGE 3 0.0005
552 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 96 0.0005
553 PERITONITIS 11 0.0005
554 INTESTINAL OBSTRUCTION 20 0.0005
555 NEUROLOGICAL SYMPTOM 3 0.0005
556 HYPERGLYCAEMIA 19 0.0005
557 EXERCISE TOLERANCE DECREASED 3 0.0005
558 MADAROSIS 6 0.0005
559 STRESS CARDIOMYOPATHY 3 0.0005
560 EPIGASTRIC DISCOMFORT 2 0.0005
561 RENAL IMPAIRMENT 43 0.0005
562 AFFECTIVE DISORDER 4 0.0005
563 CATARACT OPERATION 3 0.0005
564 AZOTAEMIA 2 0.0005
565 BLOOD DISORDER 4 0.0005
566 PLATELET COUNT ABNORMAL 3 0.0005
567 CEREBRAL INFARCTION 12 0.0005
568 ESCHERICHIA INFECTION 4 0.0005
569 NASAL DRYNESS 3 0.0005
570 DYSARTHRIA 18 0.0005
571 INFUSION SITE SWELLING 3 0.0005
572 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
573 INFECTION 68 0.0005
574 DRUG RESISTANCE 12 0.0005
575 PSEUDOMONAS INFECTION 4 0.0005
576 PLATELET COUNT INCREASED 6 0.0005
577 GASTROOESOPHAGEAL REFLUX DISEASE 37 0.0005
578 SPEECH DISORDER 24 0.0005
579 ABDOMINAL ABSCESS 2 0.0005
580 MUSCULOSKELETAL CHEST PAIN 7 0.0005
581 DENTAL CARIES 5 0.0005
582 DYSPNOEA EXERTIONAL 17 0.0005
583 CATHETERISATION CARDIAC 2 0.0005
584 BRAIN NEOPLASM MALIGNANT 2 0.0004
585 BRONCHIECTASIS 3 0.0004
586 DYSGEUSIA 33 0.0004
587 OEDEMA 24 0.0004
588 MITRAL VALVE INCOMPETENCE 5 0.0004
589 OPTIC NEURITIS 4 0.0004
590 BACK PAIN 102 0.0004
591 ECCHYMOSIS 3 0.0004
592 CELLULITIS 22 0.0004
593 RESPIRATORY DISTRESS 12 0.0004
594 GASTRIC HAEMORRHAGE 5 0.0004
595 ABDOMINAL PAIN 101 0.0004
596 ARTHRITIS INFECTIVE 2 0.0004
597 HUNGER 6 0.0004
598 VISION BLURRED 59 0.0004
599 BACTERIAL INFECTION 8 0.0004
600 EPISTAXIS 32 0.0004
601 FRACTURE 8 0.0004
602 GASTRIC ULCER 8 0.0004
603 INTENTIONAL DOSE OMISSION 12 0.0004
604 CARDIAC TAMPONADE 2 0.0004
605 OEDEMA PERIPHERAL 51 0.0004
606 NERVOUS SYSTEM DISORDER 13 0.0004
607 DEEP VEIN THROMBOSIS 27 0.0004
608 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
609 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
610 ERUCTATION 8 0.0004
611 HEMIPARESIS 7 0.0004
612 LIVER FUNCTION TEST ABNORMAL 12 0.0004
613 INTENTIONAL UNDERDOSE 3 0.0004
614 PSYCHIATRIC SYMPTOM 3 0.0004
615 HYPOPHOSPHATAEMIA 3 0.0004
616 BREATH SOUNDS ABNORMAL 2 0.0004
617 PRODUCT DOSE OMISSION ISSUE 119 0.0004
618 MOBILITY DECREASED 29 0.0004
619 PHARYNGITIS 5 0.0004
620 ORAL PAIN 9 0.0004
621 OVARIAN CYST 4 0.0004
622 SALIVARY HYPERSECRETION 4 0.0004
623 BLOOD CREATININE INCREASED 26 0.0004
624 PRODUCTIVE COUGH 19 0.0004
625 POISONING 5 0.0004
626 SLEEP DISORDER 28 0.0004
627 HEAD DISCOMFORT 7 0.0004
628 DRUG TOLERANCE 2 0.0004
629 WEIGHT INCREASED 88 0.0004
630 BONE PAIN 23 0.0004
631 INSURANCE ISSUE 6 0.0004
632 NEUTROPHIL COUNT INCREASED 4 0.0004
633 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
634 HAEMOLYSIS 3 0.0004
635 HAEMATOCHEZIA 21 0.0004
636 IMMUNE SYSTEM DISORDER 5 0.0004
637 PULMONARY CONGESTION 5 0.0004
638 FURUNCLE 3 0.0004
639 GINGIVAL PAIN 3 0.0004
640 THROMBOSIS 30 0.0004
641 ANAL ABSCESS 2 0.0004
642 PERIPHERAL SWELLING 57 0.0004
643 RENAL FAILURE 49 0.0004
644 DECUBITUS ULCER 3 0.0004
645 IMPAIRED GASTRIC EMPTYING 5 0.0004
646 AKATHISIA 5 0.0004
647 ABNORMAL FAECES 3 0.0004
648 OSTEONECROSIS 12 0.0004
649 SKIN LESION 10 0.0004
650 APHASIA 11 0.0004
651 OBSTRUCTIVE AIRWAYS DISORDER 4 0.0004
652 MASS 5 0.0004
653 URINARY TRACT INFECTION 61 0.0004
654 ANGIOPATHY 2 0.0004
655 SKIN INFECTION 4 0.0004
656 INTESTINAL PERFORATION 4 0.0004
657 OCULAR DISCOMFORT 4 0.0004
658 INFUSION SITE ERYTHEMA 3 0.0004
659 ABDOMINAL PAIN UPPER 73 0.0004
660 IMPAIRED DRIVING ABILITY 4 0.0004
661 INFLAMMATION 18 0.0003
662 DIPLOPIA 9 0.0003
663 ACUTE KIDNEY INJURY 53 0.0003
664 MYELODYSPLASTIC SYNDROME 5 0.0003
665 NEUROTOXICITY 6 0.0003
666 CARDIAC ARREST 28 0.0003
667 LYMPHADENOPATHY 12 0.0003
668 THERAPY INTERRUPTED 24 0.0003
669 CHOLECYSTITIS 4 0.0003
670 OROPHARYNGEAL DISCOMFORT 3 0.0003
671 VISUAL ACUITY REDUCED 11 0.0003
672 NEURALGIA 8 0.0003
673 RETCHING 7 0.0003
674 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
675 CHILLS 38 0.0003
676 FAECES DISCOLOURED 7 0.0003
677 HAEMOPTYSIS 9 0.0003
678 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
679 CARDIAC DISORDER 30 0.0003
680 SOMNOLENCE 64 0.0003
681 MUSCLE ATROPHY 4 0.0003
682 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
683 PRESCRIBED OVERDOSE 6 0.0003
684 UNRESPONSIVE TO STIMULI 8 0.0003
685 CARDIAC FLUTTER 2 0.0003
686 DYSSTASIA 9 0.0003
687 VITAMIN D DEFICIENCY 3 0.0003
688 HAEMORRHOIDS 6 0.0003
689 INCORRECT DOSE ADMINISTERED 70 0.0003
690 DEAFNESS 8 0.0003
691 DYSPHAGIA 29 0.0003
692 FEELING ABNORMAL 73 0.0003
693 SHOCK 7 0.0003
694 HYPOTENSION 61 0.0003
695 ABDOMINAL DISCOMFORT 51 0.0003
696 DISORIENTATION 12 0.0003
697 DEPRESSED MOOD 16 0.0003
698 DYSURIA 11 0.0003
699 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
700 PAIN OF SKIN 8 0.0003
701 DISCOMFORT 18 0.0003
702 SUBARACHNOID HAEMORRHAGE 3 0.0003
703 MOTOR DYSFUNCTION 3 0.0003
704 EUPHORIC MOOD 3 0.0003
705 SCAR 5 0.0003
706 LIMB DISCOMFORT 9 0.0003
707 ENCEPHALITIS 2 0.0003
708 EYE DISCHARGE 3 0.0003
709 TENDERNESS 3 0.0003
710 GAIT DISTURBANCE 55 0.0003
711 APHONIA 4 0.0003
712 BLOOD PRESSURE DECREASED 19 0.0003
713 DEVICE OCCLUSION 4 0.0003
714 INCONTINENCE 3 0.0003
715 BLINDNESS UNILATERAL 4 0.0003
716 HYPOTHYROIDISM 9 0.0003
717 DIVERTICULUM 2 0.0003
718 BREAST PAIN 3 0.0003
719 CHEST PAIN 52 0.0003
720 SKIN LACERATION 3 0.0003
721 PRODUCT PRESCRIBING ISSUE 6 0.0003
722 TREATMENT NONCOMPLIANCE 15 0.0003
723 DYSPHONIA 16 0.0003
724 GASTROINTESTINAL PAIN 3 0.0003
725 BLINDNESS TRANSIENT 2 0.0003
726 VIRAL INFECTION 9 0.0003
727 URINARY RETENTION 9 0.0003
728 RESPIRATORY TRACT INFECTION 7 0.0003
729 LUNG NEOPLASM MALIGNANT 11 0.0003
730 NEPHROPATHY TOXIC 3 0.0003
731 PHOTOPHOBIA 5 0.0003
732 STATUS EPILEPTICUS 3 0.0003
733 LOSS OF CONSCIOUSNESS 34 0.0003
734 FALL 88 0.0003
735 CONDITION AGGRAVATED 80 0.0003
736 INTERNAL HAEMORRHAGE 3 0.0003
737 SKIN DISCOLOURATION 12 0.0003
738 DISSOCIATION 2 0.0003
739 SYNCOPE 26 0.0003
740 DELIRIUM 9 0.0003
741 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
742 HYPERKALAEMIA 9 0.0003
743 CHOKING 5 0.0003
744 SPINAL PAIN 3 0.0003
745 NEOPLASM MALIGNANT 17 0.0003
746 PRODUCT USE COMPLAINT 4 0.0003
747 HAEMATOCRIT DECREASED 5 0.0003
748 MENTAL STATUS CHANGES 7 0.0003
749 CYSTITIS 8 0.0003
750 DIABETIC KETOACIDOSIS 6 0.0002
751 DIZZINESS 123 0.0002
752 BONE MARROW FAILURE 5 0.0002
753 CARDIOMEGALY 3 0.0002
754 INTERCEPTED PRODUCT PREPARATION ERROR 3 0.0002
755 HERPES ZOSTER 14 0.0002
756 LETHARGY 14 0.0002
757 PHOTOSENSITIVITY REACTION 4 0.0002
758 VISUAL IMPAIRMENT 30 0.0002
759 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
760 EMBOLISM 2 0.0002
761 FUNGAL INFECTION 8 0.0002
762 BLOOD UREA INCREASED 4 0.0002
763 URINARY INCONTINENCE 7 0.0002
764 CIRCULATORY COLLAPSE 4 0.0002
765 CHEST DISCOMFORT 24 0.0002
766 IMPAIRED WORK ABILITY 5 0.0002
767 HAEMATURIA 8 0.0002
768 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
769 ANURIA 2 0.0002
770 RHINORRHOEA 15 0.0002
771 PARANOIA 4 0.0002
772 BALANCE DISORDER 20 0.0002
773 HEADACHE 144 0.0002
774 MUSCULAR WEAKNESS 26 0.0002
775 BLOOD CALCIUM INCREASED 2 0.0002
776 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
777 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
778 EYE HAEMORRHAGE 3 0.0002
779 HAIR TEXTURE ABNORMAL 3 0.0002
780 GALLBLADDER DISORDER 4 0.0002
781 THIRST 4 0.0002
782 DIABETES MELLITUS 17 0.0002
783 PARAESTHESIA 35 0.0002
784 PANCREATITIS ACUTE 5 0.0002
785 ANAL INCONTINENCE 2 0.0002
786 HEART RATE IRREGULAR 5 0.0002
787 LEUKOCYTOSIS 4 0.0002
788 BLINDNESS 9 0.0002
789 TACHYPNOEA 3 0.0002
790 GINGIVAL BLEEDING 3 0.0002
791 METABOLIC ACIDOSIS 7 0.0002
792 PAIN 134 0.0002
793 MOVEMENT DISORDER 7 0.0002
794 HIP FRACTURE 7 0.0002
795 BLOOD GLUCOSE ABNORMAL 4 0.0002
796 FLUID RETENTION 11 0.0002
797 CONJUNCTIVITIS 4 0.0002
798 COGNITIVE DISORDER 10 0.0002
799 ILL-DEFINED DISORDER 13 0.0002
800 SINUS TACHYCARDIA 3 0.0002
801 COMA 10 0.0002
802 HYPOACUSIS 9 0.0002
803 LOWER LIMB FRACTURE 4 0.0002
804 TYPE 2 DIABETES MELLITUS 7 0.0002
805 AFFECT LABILITY 2 0.0002
806 ANOSMIA 3 0.0002
807 HYPOAESTHESIA 31 0.0002
808 MENTAL DISORDER 9 0.0002
809 MYALGIA 35 0.0002
810 APATHY 3 0.0002
811 ORAL HERPES 4 0.0002
812 MEMORY IMPAIRMENT 28 0.0002
813 ENCEPHALOPATHY 5 0.0002
814 TACHYCARDIA 18 0.0002
815 SKIN HAEMORRHAGE 3 0.0002
816 PRODUCT USE ISSUE 38 0.0002
817 HAEMORRHAGE INTRACRANIAL 3 0.0002
818 AMNESIA 13 0.0002
819 SPINAL FRACTURE 4 0.0002
820 BRAIN INJURY 2 0.0002
821 HYPOAESTHESIA ORAL 3 0.0002
822 INSOMNIA 53 0.0002
823 INFLUENZA 22 0.0002
824 DRY MOUTH 16 0.0002
825 PAIN IN EXTREMITY 58 0.0002
826 FEELING HOT 12 0.0002
827 EAR DISCOMFORT 2 0.0002
828 THYROID DISORDER 3 0.0002
829 ANKLE FRACTURE 3 0.0002
830 TREATMENT FAILURE 16 0.0002
831 DERMATITIS 4 0.0002
832 ARRHYTHMIA 9 0.0002
833 ULCER 3 0.0002
834 BODY HEIGHT DECREASED 2 0.0002
835 FEAR 5 0.0002
836 DECREASED ACTIVITY 2 0.0002
837 MUSCLE SPASMS 34 0.0002
838 OROPHARYNGEAL PAIN 17 0.0002
839 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
840 HOSPITALISATION 28 0.0002
841 STAPHYLOCOCCAL INFECTION 6 0.0002
842 MELAENA 4 0.0002
843 RESPIRATORY ARREST 5 0.0002
844 RASH 79 0.0002
845 CYTOMEGALOVIRUS INFECTION 3 0.0002
846 SKIN DISORDER 6 0.0002
847 TOOTH DISORDER 4 0.0002
848 NASOPHARYNGITIS 33 0.0002
849 PERICARDITIS 3 0.0002
850 SNEEZING 4 0.0002
851 BLISTER 10 0.0002
852 FACE OEDEMA 3 0.0002
853 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
854 CHROMATURIA 4 0.0002
855 DERMATITIS CONTACT 2 0.0002
856 RENAL DISORDER 8 0.0002
857 BRADYCARDIA 9 0.0002
858 GASTROINTESTINAL HAEMORRHAGE 14 0.0002
859 GASTROENTERITIS VIRAL 3 0.0002
860 RASH PRURITIC 9 0.0002
861 LACRIMATION INCREASED 5 0.0002
862 ANXIETY 47 0.0002
863 CRYING 6 0.0002
864 VERTIGO 10 0.0002
865 RECTAL HAEMORRHAGE 7 0.0002
866 EMOTIONAL DISORDER 5 0.0002
867 CONFUSIONAL STATE 26 0.0002
868 DERMATITIS ALLERGIC 2 0.0002
869 GASTRIC CANCER 4 0.0002
870 FEELING JITTERY 3 0.0002
871 INCREASED APPETITE 3 0.0002
872 DRUG INEFFECTIVE 205 0.0002
873 HAEMATOMA 4 0.0002
874 CHOLELITHIASIS 5 0.0002
875 TINNITUS 7 0.0002
876 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
877 PANCREATITIS 8 0.0002
878 EAR INFECTION 4 0.0002
879 SWELLING 14 0.0001
880 BRONCHITIS 11 0.0001
881 ANGER 5 0.0001
882 CORONARY ARTERY OCCLUSION 2 0.0001
883 HYPOGLYCAEMIA 7 0.0001
884 FEELING COLD 4 0.0001
885 CARDIO-RESPIRATORY ARREST 6 0.0001
886 HAEMORRHAGE 15 0.0001
887 HEART RATE INCREASED 14 0.0001
888 CARDIOGENIC SHOCK 2 0.0001
889 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
890 SWELLING FACE 9 0.0001
891 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
892 FLUSHING 14 0.0001
893 PALPITATIONS 16 0.0001
894 AGITATION 10 0.0001
895 ACUTE MYOCARDIAL INFARCTION 4 0.0001
896 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
897 GLOSSODYNIA 3 0.0001
898 THERAPY NON-RESPONDER 6 0.0001
899 PRODUCT AVAILABILITY ISSUE 3 0.0001
900 SKIN EXFOLIATION 11 0.0001
901 BURNING SENSATION 9 0.0001
902 RASH ERYTHEMATOUS 6 0.0001
903 LOCALISED INFECTION 3 0.0001
904 PRESYNCOPE 3 0.0001
905 DYSKINESIA 5 0.0001
906 EYE DISORDER 4 0.0001
907 TREMOR 20 0.0001
908 ARTHRALGIA 50 0.0001
909 LIP SWELLING 4 0.0001
910 COAGULOPATHY 2 0.0001
911 DRY SKIN 16 0.0001
912 HOT FLUSH 9 0.0001
913 SURGERY 7 0.0001
914 NASAL CONGESTION 7 0.0001
915 ABDOMINAL PAIN LOWER 3 0.0001
916 CARDIOVASCULAR DISORDER 3 0.0001
917 WHEEZING 7 0.0001
918 BLOOD GLUCOSE INCREASED 22 0.0001
919 ERYTHEMA 24 0.0001
920 IRRITABILITY 7 0.0001
921 ANAPHYLACTIC SHOCK 3 0.0001
922 SEDATION 3 0.0001
923 HYPERSENSITIVITY 21 0.0001
924 CARDIAC FAILURE CONGESTIVE 9 0.0001
925 BONE DISORDER 2 0.0001
926 PROCEDURAL PAIN 3 0.0001
927 DEMENTIA 3 0.0001
928 WOUND 3 0.0001
929 BLOOD URINE PRESENT 2 0.0001
930 MIGRAINE 10 0.0001
931 ANGINA PECTORIS 3 0.0001
932 EYE IRRITATION 6 0.0001
933 CONTUSION 10 0.0001
934 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
935 MYOCARDIAL INFARCTION 18 0.0001
936 EAR PAIN 2 0.0001
937 PRODUCT STORAGE ERROR 9 0.0001
938 MUSCULOSKELETAL STIFFNESS 9 0.0001
939 OESOPHAGEAL CARCINOMA 3 0.0001
940 DEPRESSION 23 0.0001
941 DRUG INTERACTION 16 0.0001
942 BLOOD PRESSURE ABNORMAL 2 0.0001
943 JOINT SWELLING 12 0.0001
944 BODY TEMPERATURE INCREASED 2 0.0001
945 SWOLLEN TONGUE 3 0.0001
946 MUSCULOSKELETAL PAIN 5 0.0001
947 HEAD INJURY 3 0.0001
948 HALLUCINATION 7 0.0001
949 ATRIAL FIBRILLATION 9 0.0001
950 IMPAIRED HEALING 3 0.0001
951 ANAPHYLACTIC REACTION 5 0.0001
952 HYPERTENSION 19 0.0001
953 COLITIS ULCERATIVE 4 0.0001
954 EYE PRURITUS 3 0.0001
955 SKIN IRRITATION 4 0.0001
956 RASH MACULAR 3 0.0001
957 HEART RATE DECREASED 3 0.0001
958 INFLUENZA LIKE ILLNESS 7 0.0001
959 BLOOD PRESSURE FLUCTUATION 2 0.0001
960 BLOOD GLUCOSE DECREASED 4 0.0001
961 CEREBROVASCULAR ACCIDENT 14 0.0001
962 EYE SWELLING 3 0.0001
963 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
964 NERVOUSNESS 4 0.0001
965 PRURITUS 29 0.0001
966 OSTEOPOROSIS 3 0.0001
967 DIVERTICULITIS 2 0.0001
968 BLOOD PRESSURE INCREASED 11 0.0001
969 POLLAKIURIA 3 0.0001
970 NECK PAIN 4 0.0001
971 EYE PAIN 4 0.0001
972 HYPERHIDROSIS 9 0.0001
973 SKIN BURNING SENSATION 5 0.0001
974 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
975 DEVICE DISLOCATION 3 0.0001
976 PRODUCT USE IN UNAPPROVED INDICATION 17 0.0001
977 INTENTIONAL PRODUCT MISUSE 6 0.0001
978 THROAT IRRITATION 3 0.0001
979 EMOTIONAL DISTRESS 8 0.0001
980 CHRONIC KIDNEY DISEASE 5 0.0001
981 SUICIDAL IDEATION 6 0.0001
982 NEPHROLITHIASIS 3 0.0001
983 OCULAR HYPERAEMIA 3 0.0001
984 COLORECTAL CANCER 3 0.0001
985 SINUSITIS 6 0.0001
986 DISTURBANCE IN ATTENTION 3 0.0001
987 OVERDOSE 12 0.0001
988 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
989 ARTHROPATHY 3 0.0001
990 ASTHMA 6 0.0001
991 ANGIOEDEMA 2 0.0000
992 DEVICE MALFUNCTION 3 0.0000
993 ARTHRITIS 3 0.0000
994 RHEUMATOID ARTHRITIS 4 0.0000
995 INJECTION SITE PAIN 3 0.0000